Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Age
Any age
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Postmenopausal women on glucocorticoids (prednisone 5mg/d or greater
Osteopenia by T score of hip or lumbar spine of -2.0
All study subjects must be on a stable dose of estrogen/progesterone or raloxifene
Ambulatory and able to come to the clinical center 9 times over 2 years
Willing to sign an informed consent
You may not be if
Generalized disease of the bone (other than glucocorticoid-induced osteoporosis), including hyperparathyroidism, hyperthyroidism, Paget's disease)
Diseases that affect bone metabolism (e.g. alcoholism, inflammatory bowel disease, malabsorption, renal disease (Cr2) or liver disease (transaminase level 2 times limit of normal)
Within the past 1 year, regular use of medications that are known to affect bone metabolism (e.g. anabolic steroids, anticoagulants, anticonvulsants, pharmacologic doses of vitamin D and vitamin A supplements).
History of drug abuse
Senile dementia, paraplegia and/or quadriplegia
Unstable rheumatic disease with clinically significant renal or central nervous system involvement.
